Drug class
Vascular Endothelial Growth Factor Receptor 2 Antagonist
Mechanism of action
VEGFR2 Inhibitors
General use cases
- Carcinoma, Non-Small-Cell Lung
- Stomach Neoplasms
- Colorectal Neoplasms
For general informational purposes only. Do not rely on, cross-reference, cite or use this information as evidence or support for legal, regulatory, commercial or other claims.
